SEC Form D · Amendment · filed January 9, 2020
Amplyx Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (27)
Michael Grey · San Diego, CADirectorCiara Kennedy · San Diego, CAExec · DirectorPaul Grint · Claremont, CADirectorElaine Heron · San Diego, CADirectorJohan Kordel · San Diego, CADirectorEdward Mathers · Cambridge, MADirectorAnand Mehra · Menlo Park, CADirectorNiall Odonnell · San Diego, CADirectorCRC Opportunistic Retail Fund I General Partner, LLC · Baltimore, MDDirectorFelix Shalit · Carmel, INExec · DirectorVaibhav Agrawal · Frisco, TXDirectorHarshjit Sethi · Frisco, TXDirectorManager of the General Partner CRC Opportunistic Retail Fund I GP Manager, LLC · Baltimore, MDDirectorNirmit Parikh · Frisco, TXDirectorMichael R. Ross · Salt Lake City, UTDirectorAlan Fuhrman · San Diego, CAExecMike Hodges · San Diego, CAExecMicaela Kelley · London, United KingdomDirectorAndrew Skatoff · Santa Monica, CAExec · DirectorTamerlan Abdikeev · London, United KingdomDirectorIain Rawlinson · London, United KingdomDirectorJames Nieuwenhuys · London, United KingdomDirectorChristian Schaffalitzky · London, United KingdomDirectorTed L. Hill · BOSTON, MADirectorJohan Kordel · Hellerup, NetherlandsDirectorAlan Fuhrman · San Diego, CAExecMike Hodges · San Diego, CAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗